Finance

Beta
Lists
KTTA:NASDAQ
Pasithea Therapeutics Corp
$0.58
-5.63%
(-0.035) 1D
$0.59
+0.85% (+0.0050)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KTTA...
Open
$0.62
High
$0.62
Low
$0.58
Mkt. cap
19.55M
Avg. vol.
431.32K
Volume
389.96K
52-wk high
$2.06
52-wk low
$0.28
EPS
-$1.98
Beta
0.25
Shares outstanding
33.41M
No. of employees
5
Open
$0.62
High
$0.62
Low
$0.58
Mkt. cap
19.55M
Avg. vol.
431.32K
Volume
389.96K
52-wk high
$2.06
52-wk low
$0.28
EPS
-$1.98
Beta
0.25
Shares outstanding
33.41M
No. of employees
5
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to KTTA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for KTTA in the last 3 months.
Highest
Current $0.58
$3.00 (+412.82%)
Average
$3.00 (+412.82%)
Lowest
$3.00 (+412.82%)
News stories
From sources across the web
About Pasithea Therapeutics Corp
CEO-
Employees5
Founded2020
HeadquartersMiami Beach, Florida, United States
SectorBiotechnology
Websitepasithea.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.15M
1.36M
2.74M
2.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.66M
1.75M
3.35M
1.93M
Operating expense
3.81M
3.11M
6.09M
4.88M
Total operating expenses
3.81M
3.11M
6.09M
4.88M
Operating income
-3.81M
-3.11M
-6.09M
-4.88M
Other non operating income
11.03K
55.49K
-64.17K
1.57M
EBT including unusual items
-3.72M
-3.04M
-10.11M
-2.87M
EBT excluding unusual items
-3.72M
-3.04M
-5.95M
-2.87M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.72M
-3.04M
-10.11M
-2.87M
Net profit margin
-
-
-
-
Earnings per share
-
-
-0.89
-0.12
Interest and investment income
54.42K
43.40K
182.13K
450.34K
Interest expense
-
-
-
-
Net interest expenses
54.42K
43.40K
182.13K
450.34K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.65M
-2.93M
-5.93M
-4.72M
Gain or loss from assets sale
-
-
103.32K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer